Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Borsig, L; Wolf, M J; Roblek, M; Lorentzen, A; Heikenwalder, M (2014). Inflammatory chemokines and metastasis-tracing the accessory. Oncogene, 33(25):3217-3224.

Hoos, A; Wolf, M J; Bauer, J; Borsig, L; Heikenwalder, M (2012). Endothelial chemokine receptors as facilitators of tumor cell extravasation? OncoTarget, 3(9):919-920.

Wolf, M J; Seleznik, G M; Heikenwalder, M (2011). Lymphotoxin's link to carcinogenesis: friend or foe? from lymphoid neogenesis to hepatocellular carcinoma and prostate cancer. In: Wallach, D; Kovalenko, A; Feldmann, M. Advances in TNF Family Research. New York: Springer, 231-249.

Wolf, M J. Novel insights into the functions of CCR2 in tumor cell metastasis and lymphotoxin in liver cancer development. 2011, University of Zurich, Faculty of Science.

Bettermann, K; Vucur, M; Haybaeck, J; Koppe, C; Janssen, J; Heymann, F; Weber, A; Weiskirchen, R; Liedtke, C; Gassler, N; Müller, M; de Vos, R; Wolf, M J; Boege, Y; Seleznik, G M; Zeller, N; Erny, D; Fuchs, T; Zoller, S; Cairo, S; Buendia, M A; Prinz, M; Akira, S; Tacke, F; Heikenwalder, M; Trautwein, C; Luedde, T (2010). TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell, 17(5):481-496.

Wolf, M J; Seleznik, G M; Zeller, N; Heikenwalder, M (2010). The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene, 29(36):5006-1508.

Haybaeck, J; Zeller, N; Wolf, M J; Weber, A; Wagner, U; Kurrer, M O; Bremer, J; Iezzi, G; Graf, R; Clavien, P A; Thimme, R; Blum, H; Nedospasov, S A; Zatloukal, K; Ramzan, M; Ciesek, S; Pietschmann, T; Marche, P N; Karin, M; Kopf, M; Browning, J L; Aguzzi, A; Heikenwalder, M (2009). A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell, 16(4):295-308.

This list was generated on Sat Sep 23 09:47:15 2017 CEST.